(3) http://www.annals.org/content/138/4/273.abstract
Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending, part 1: the content, quality, and accessibility of care. Ann Intern Med. 2003;138(4):273-287.
(4)http://jama.ama-assn.org/cgi/content/abstract/288/3/321
Rossouw JE, Anderson GL, Prentice RL; et al, Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333.
(5) http://jeffreydach.com/2008/06/27/the-safety-of-bioidentical-hormones-by-jeffrey-dach-md.aspx
The safety of bioidentical Hormones by Jeffrey Dach MD
(6) http://www.drdach.com/BioIdentical_Hormones.html
The Importance of bio-identical Hormones by Jeffrey Dach MD
(7) http://content.nejm.org/cgi/content/abstract/347/2/81
Moseley JB, O'Malley K, Petersen NJ; et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002;347(2):81-88.
(8) http://jeffreydach.com/2007/05/22/the-power-of-the-placebo--by-jeffrey-dach-md.aspx
The Power of the Placebo by Jeffrey Dach MD
(9) http://jama.ama-assn.org/cgi/content/abstract/303/1/47
Fournier JC, DeRubeis RJ, Hollon SD; et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303(1):47-53.
(10)
http://jeffreydach.com/2010/01/21/jama-says-ssri-antidepressants-are-placebos-by-jeffrey-dach-md.aspx
Antidepressants Found to Be No Better Than Placebo.
(11) http://jama.ama-assn.org/cgi/content/full/303/2/164
Woloshin S, Schwartz LM. The benefits and harms of mammography screening: understanding the trade-offs. JAMA. 2010;303(2):164-165.
(12)
http://jeffreydach.com/2009/11/17/mammogram-guideline-reversal-by-jeffrey-dach-md.aspx
Mammogram Guideline Reversal by Jeffrey Dach MD
(13) http://archinte.ama-assn.org/cgi/content/abstract/170/9/765
9. Gray SL, LaCroix AZ, Larson J; et al. Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative. Arch Intern Med. 2010;170(9):765-771. FREE FULL TEXT
(14) http://archinte.ama-assn.org/cgi/content/abstract/170/9/784
10. Howell MD, Novack V, Grgurich P; et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med. 2010;170(9):784-790. FREE FULL TEXT
(15) http://archinte.ama-assn.org/cgi/content/abstract/170/9/772
11. Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med. 2010;170(9):772-778. FREE FULL TEXT
(16) http://www.annals.org/content/149/6/391.abstract
12. Sarkar M, Hennessy S, Yang Y-X. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med. 2008;149(6):391-398.
(17)http://jama.ama-assn.org/cgi/content/abstract/301/20/2120
13. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid suppressive medication use and the risk for hospital acquired pneumonia. JAMA. 2009;301(20):2120-2128.
(18) http://archinte.ama-assn.org/cgi/content/full/170/9/747
14. Katz MH. Failing the acid test: benefits of proton pump inhibitors may not justify the risks for many users. Arch Intern Med. 2010;170(9):747-748.
Fisher ES, Wennberg DE, Stukel TA, Gottlieb DJ, Lucas FL, Pinder EL. The implications of regional variations in Medicare spending, part 1: the content, quality, and accessibility of care. Ann Intern Med. 2003;138(4):273-287.
(4)http://jama.ama-assn.org/cgi/content/abstract/288/3/321
Rossouw JE, Anderson GL, Prentice RL; et al, Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA. 2002;288(3):321-333.
(5) http://jeffreydach.com/2008/06/27/the-safety-of-bioidentical-hormones-by-jeffrey-dach-md.aspx
The safety of bioidentical Hormones by Jeffrey Dach MD
(6) http://www.drdach.com/BioIdentical_Hormones.html
The Importance of bio-identical Hormones by Jeffrey Dach MD
Moseley JB, O'Malley K, Petersen NJ; et al. A controlled trial of arthroscopic surgery for osteoarthritis of the knee. N Engl J Med. 2002;347(2):81-88.
(8) http://jeffreydach.com/2007/05/22/the-power-of-the-placebo--by-jeffrey-dach-md.aspx
The Power of the Placebo by Jeffrey Dach MD
(9) http://jama.ama-assn.org/cgi/content/abstract/303/1/47
Fournier JC, DeRubeis RJ, Hollon SD; et al. Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA. 2010;303(1):47-53.
(10)
http://jeffreydach.com/2010/01/21/jama-says-ssri-antidepressants-are-placebos-by-jeffrey-dach-md.aspx
Antidepressants Found to Be No Better Than Placebo.
(11) http://jama.ama-assn.org/cgi/content/full/303/2/164
Woloshin S, Schwartz LM. The benefits and harms of mammography screening: understanding the trade-offs. JAMA. 2010;303(2):164-165.
(12)
http://jeffreydach.com/2009/11/17/mammogram-guideline-reversal-by-jeffrey-dach-md.aspx
Mammogram Guideline Reversal by Jeffrey Dach MD
(13) http://archinte.ama-assn.org/cgi/content/abstract/170/9/765
9. Gray SL, LaCroix AZ, Larson J; et al. Proton pump inhibitor use, hip fracture, and change in bone mineral density in postmenopausal women: results from the Women's Health Initiative. Arch Intern Med. 2010;170(9):765-771. FREE FULL TEXT
(14) http://archinte.ama-assn.org/cgi/content/abstract/170/9/784
10. Howell MD, Novack V, Grgurich P; et al. Iatrogenic gastric acid suppression and the risk of nosocomial Clostridium difficile infection. Arch Intern Med. 2010;170(9):784-790. FREE FULL TEXT
(15) http://archinte.ama-assn.org/cgi/content/abstract/170/9/772
11. Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch Intern Med. 2010;170(9):772-778. FREE FULL TEXT
(16) http://www.annals.org/content/149/6/391.abstract
12. Sarkar M, Hennessy S, Yang Y-X. Proton-pump inhibitor use and the risk for community-acquired pneumonia. Ann Intern Med. 2008;149(6):391-398.
(17)http://jama.ama-assn.org/cgi/content/abstract/301/20/2120
13. Herzig SJ, Howell MD, Ngo LH, Marcantonio ER. Acid suppressive medication use and the risk for hospital acquired pneumonia. JAMA. 2009;301(20):2120-2128.
(18) http://archinte.ama-assn.org/cgi/content/full/170/9/747
14. Katz MH. Failing the acid test: benefits of proton pump inhibitors may not justify the risks for many users. Arch Intern Med. 2010;170(9):747-748.
(Note: You can view every article as one long page if you sign up as an Advocate Member, or higher).
1
